Will CROs Find Opportunity in a Reinvigorated European R&D Sector? Outsourcing Outlook

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-10-02-2002, Volume 26, Issue 10

The European Union is attempting to reform its current business environment in hopes of restoring its role in the lobal R&D sector.

Related Content:

Bio/Pharma BusinessProcess ValidationOutsourcingOutsourcing OutlookDevelopmentContract Manufacturing, GeneralPharmaceutical Technology-10-02-2002
N4 Pharma and SRI to Collaborate on Intracellular Delivery to Specific Target Cells
How New Regulations Are Impacting Pharmaceutical Manufacturing Facility Design
CordenPharma Leverages Peptide Drug Discovery and Development with GENEPEP and Works on Reducing Emissions